Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lupus Erythematosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableWithdrawnNCT02450396
What this trial is testing

Pregnancy and Medically Assisted Conception in Rare Diseases

Who this might be right for
Rheumatoid ArthritisSpondyloarthritisPsoriatic Arthritis+8 more
Assistance Publique - Hôpitaux de Paris
Large-scale testing (Phase 3)Active Not RecruitingNCT04877691
What this trial is testing

Subcutaneous Anifrolumab in Adult Patients With Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
AstraZeneca 367
Post-approval studies (Phase 4)Looking for participantsNCT06875960
What this trial is testing

Continue the Administration of Deucravacitinib in Participants With Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) Who Have Completed Study IM011074 or Study IM011132

Who this might be right for
Systemic Lupus Erythematosus (SLE)Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE)
Bristol-Myers Squibb 35
Testing effectiveness (Phase 2)UnknownNCT00698191
What this trial is testing

Mesenchymal Stem Cells Transplantation for Refractory Systemic Lupus Erythematosus (SLE)

Who this might be right for
Refractory Systemic Lupus Erythematosus
Nanjing Medical University 20
Early research (Phase 1)Not Yet RecruitingNCT06852573
What this trial is testing

Clinical Study of ZM001 Injection in the Treatment of Refractory Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Beijing Immunochina Medical Science & Technology Co., Ltd. 18
Not applicableStudy completedNCT04522505
What this trial is testing

Long-term Follow-up for Evaluating the Safety of CS20AT04 in Subject with Lupus Nephritis

Who this might be right for
Lupus Nephritis
Corestemchemon, Inc. 6
Testing effectiveness (Phase 2)Study completedNCT05162586
What this trial is testing

The WILLOW Study With M5049 in SLE and CLE (SCLE and/or DLE) (WILLOW)

Who this might be right for
Systemic Lupus Erythematosus
EMD Serono Research & Development Institute, Inc. 456
Not applicableLooking for participantsNCT06462768
What this trial is testing

Neutrophil Extracellular Traps in Different Forms of Systemic Sclerosis

Who this might be right for
Systemic SclerosisOther Connective Tissue DiseaseSystemic Lupus Erythematosus+2 more
CHU de Reims 260
Not applicableUnknownNCT06255743
What this trial is testing

(Anti-Ribosomal P Protein,Anti-U1 RNP, Anti-Nucleosome and Anti-ds DNA Antibodies) and Relation to Depression and Anxiety in SLE

Who this might be right for
Systemic Lupus Erythematosus
Sohag University 50
Testing effectiveness (Phase 2)WithdrawnNCT00390091
What this trial is testing

Study of LJP 394 (Abetimus Sodium) in Lupus Patients

Who this might be right for
Systemic Lupus Erythematosus
La Jolla Pharmaceutical Company
Not applicableStudy completedNCT02281513
What this trial is testing

Activity and Nutrition Trial in Lupus to Energize and Renew

Who this might be right for
Systemic Lupus ErythematosusPhysical ActivitySleep
Northwestern University 12
Not applicableUnknownNCT03804723
What this trial is testing

Glucocorticoids Withdrawal in Early Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus ErythematosusGlucocorticoidsTherapy Withdrawal
University of Pisa 321
Large-scale testing (Phase 3)UnknownNCT00053560
What this trial is testing

To Assess Prevention of Bone Loss in Women With Lupus Receiving Treatment With Glucocorticoids

Who this might be right for
Lupus
Genelabs Technologies 155
Testing effectiveness (Phase 2)Study completedNCT02437890
What this trial is testing

A Phase II Study to Evaluate Safety and Efficacy of ALX-0061 in Subjects With Systemic Lupus Erythematosus

Who this might be right for
Lupus Erythematosus, Systemic
Ablynx, a Sanofi company 312
Testing effectiveness (Phase 2)Looking for participantsNCT07348055
What this trial is testing

GR1803 in Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus ErthematosusAuto Immune Disease
Genrix (Shanghai) Biopharmaceutical Co., Ltd. 44
Testing effectiveness (Phase 2)Study completedNCT00054938
What this trial is testing

Prevention of Atherosclerosis and Heart Disease in Patients With Systemic Lupus Erythematosis (SLE)

Who this might be right for
Systemic Lupus ErythematosusLupus
Brigham and Women's Hospital 150
Large-scale testing (Phase 3)Ended earlyNCT00539838
What this trial is testing

Evaluate Two Doses of Ocrelizumab in Patients With Active Systemic Lupus Erythematosus (BEGIN)

Who this might be right for
Systemic Lupus Erythematosus
Genentech, Inc. 33
Not applicableStudy completedNCT01689350
What this trial is testing

A Prospective Study of Cyclophosphamide in Systemic Lupus Erythematosus Treatment

Who this might be right for
Systemic Lupus Erythematosus
Sun Yat-sen University 92
Testing effectiveness (Phase 2)Ended earlyNCT03355482
What this trial is testing

MRI Evaluation Assessing Synovitis to Address the Unmet Need for Reliable Endpoints in SLE

Who this might be right for
Systemic Lupus Erythematosus Arthritis
Oklahoma Medical Research Foundation 9
Very early researchUnknownNCT05030779
What this trial is testing

CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus ErythematosusAutoimmune Diseases
Zhejiang University 9
Next Page